February 11, 2020 / 11:47 AM / 14 days ago

BRIEF-Hemogenyx Pharmaceuticals Says Post-Natal Hemogenic Endothelial Cells & Their Isolation & Use Application Approved By U.S. Patent & Trademark Office

Feb 11 (Reuters) - Hemogenyx Pharmaceuticals PLC:

* HEMOGENYX PHARMACEUTICALS - POST-NATAL HEMOGENIC ENDOTHELIAL CELLS & THEIR ISOLATION & USE APPLICATION APPROVED BY U.S. PATENT & TRADEMARK OFFICE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below